Inflammatory and pro-angiogenic mediators

Inflammatory and pro-angiogenic mediators refer to a diverse group of signaling molecules, such as Vascular Endothelial Growth Factor (VEGF), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-α), that play a pivotal role in the progression of chronic liver inflammation to hepatocellular carcinoma (HCC) (Source: PMID: 30234773). These mediators facilitate angiogenesis, providing the necessary blood supply for tumor growth, while also maintaining a pro-inflammatory microenvironment that promotes genomic instability and cell survival (Source: NIH, National Cancer Institute). In liver disease, the persistent secretion of these factors by hepatocytes, stellate cells, and immune cells leads to fibrosis and eventual malignancy (Source: Journal of Hepatology). Therapeutic intervention typically involves multi-kinase inhibitors like Sorafenib or monoclonal antibodies like Bevacizumab, which target specific components of this mediator network to starve the tumor of blood and reduce inflammation (Source: PubChem). Because this term describes a functional collective of proteins rather than a single molecular entity, it is not a discrete therapeutic target but a pathological axis. Clinical management often involves monitoring these mediators as biomarkers to gauge disease severity and treatment response (Source: Mayo Clinic). The interplay between these factors creates a feedback loop where inflammation induces angiogenesis, and new vessels further recruit inflammatory cells (Source: Nature Reviews Cancer). Targeting this axis is a cornerstone of modern oncology, though resistance often develops due to the redundancy of the mediators involved (Source: ScienceDirect).

Other names

Pro-inflammatory and pro-angiogenic factorsAngiogenic-inflammatory cytokinesInflammatory-angiogenic axis factors

Inhibition of specific signaling proteins within the inflammatory and angiogenic pathways, such as VEGF receptors or IL-6 receptors, to suppress tumor growth and chronic tissue damage (Source: PubChem).